These data indicated that DDX3X enrichment might play a critical role in promoting PHGDH translation in cisplatin-resistant ovarian cancer cells, while additional factor(s) are necessary for its recruitment to the PHGDH mRNA. The gene discussed is DDX3X; the disease is ovarian cancer.